Stockscreener 앱 받기
0.00
100.00%
-11.80
시간 외 거래:
12.00
12.00
+
전일 마감가:
$11.80
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$42.05M
수익:
$11.57M
순이익/손실:
$-16.07M
주가수익비율:
0.00
EPS:
-5.3918
순현금흐름:
$-12.14M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$13.50
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
명칭
Ekso Bionics Holdings Inc
전화
510-984-1761
주소
101 GLACIER POINT, SAN RAFAEL
Compare EKSO vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EKSO
Ekso Bionics Holdings Inc
|
0.00 | 42.05M | 11.57M | -16.07M | -12.14M | -5.3918 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2016-10-14 | 개시 | SunTrust | Buy |
Ekso Bionics Holdings Inc 주식(EKSO)의 최신 뉴스
CHRN|Ekso Bionics Ord Shs|Price:21.500|Chg%:-1.070 - TradingKey
Smart Exoskeleton Market Size Forecast to USD 1,937.6 Million - openPR.com
ChronoScale Holdings Stock Jumps 16.68% as Company's AI Infrastructure Play Continues Wild Streak - International Business Times Australia
EKSO stock stays anchored by Ekso Bionics' rehab robotics - AD HOC NEWS
Ekso Bionics stock leans on robotics rehab model. Nasdaq listing stays in view. - ad-hoc-news.de
Ekso Bionics Holdings Inc (EKSO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ekso Bionics Holdings Inc (EKSO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ekso Bionics Holdings Inc (EKSO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ekso Bionics Holdings Inc (EKSO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ekso Bionics (EKSO) Holds Gains as Stock Tests Near-Term Resistance LevelsIchimoku Cloud - newsline.com
Ekso Bionics Holdings Stock (US2826641040): Ticker Change To ChronoScale Raises Questions For Legacy - AD HOC NEWS
Ekso Bionics (EKSO) Shows Modest Gains as Shares Approach Resistance LevelStock Buy Zone - newsline.com
Chronoscale To Divest Ekso Bionics And Focus On Cloud Business - TradingView
ChronoScale (NASDAQ: CHRN) plans Ekso divestiture to become cloud-focused - Stock Titan
Industrial Exoskeletons Market Is Going to Boom |• Ekso Bionics • SuitX • Sarcos Robotics - openPR.com
ChronoScale Corporation: Shareholders Board Members Managers and Company Profile | US1709241046 - marketscreener.com
Ekso Bionics (EKSO) Climbs 1.29% as Stock Tests Key Resistance LevelTechnical Analysis Picks - The Legal Advocate
Ekso Bionics (EKSO) Gains Ground as Shares Approach Key ResistanceFactor Timing - The Legal Advocate
CHRN - Finviz
Ekso Bionics (EKSO) Moves Higher as Stock Tests Resistance Near $12.39Zero Lag EMA - The Legal Advocate
ChronoScale Corporation (formerly Ekso Bionics) Files 8-K/A Amendment Detailing Phantom PSU Awards for Executives - Minichart
ChronoScale (CHRN) shifts executive phantom PSU payouts to stock and cash - Stock Titan
ChronoScale Corp (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan
ChronoScale (CHRN) director Wes Cummins granted 200,000 restricted shares in equity award - Stock Titan
[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity - Stock Titan
Richard Nottenburg awarded 200K ChronoScale (CHRN) restricted shares - Stock Titan
ChronoScale (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan
ChronoScale (CHRN) director receives 109,357-share equity grant in Form 4 filing - Stock Titan
Sports Exoskeleton Market to Reach USD 1,543.98 Million by 2033 - openPR.com
Ekso Bionics Holdings stock (US2826641040): Q1 2026 results and exoskeleton strategy in focus - AD HOC NEWS
ChronoScale (CHRN) director Richard Nottenburg files Form 3 with no trades - Stock Titan
ChronoScale Corp (CHRN) director reports 3.56M shares tied to incentive plan units - Stock Titan
Armistice Capital (CHRN) reports 187,151 shares, 4.99% ownership - Stock Titan
ChronoScale (CHRN) CEO and director file initial insider ownership - Stock Titan
CHRN SEC FilingsChronoScale Corp 10-K, 10-Q, 8-K Forms - Stock Titan
EKSO SEC FilingsEkso Bionics 10-K, 10-Q, 8-K Forms - Stock Titan
Ekso Bionics Holdings stock (US2826641040): Pioneering exoskeleton tech for medical and industrial u - AD HOC NEWS
Mink Brook amendment shows 0 CHRN shares held by related entities (CHRN) - Stock Titan
Walk Assist Robot Market Research Report 2026-2031: Leading firms Such as Ekso Bionics, Lifeward, Cyberdyne, Ottobock, and DIH Medical Lead the $568.81 Million Market - Yahoo Finance
TradingKey - TradingKey
Applied Digital gains control of ChronoScale (NASDAQ: EKSO) with 97.5% stake - Stock Titan
Exoskeleton News, May 2026 – Week 19 – Numerous new events and much more… - Exoskeleton Report
Applied Digital Just Spun Out ChronoScale: What CHRN Means for APLD Stock Now - TechStock²
ChronoScale names Cenly Chen CEO to drive AI compute expansion - MSN
CHRN Should I Buy - Intellectia AI
Ekso Bionics Holdings: Fundamental Analysis and Financial Ratings | EKSO | US2826444000 - marketscreener.com
ChronoScale Corporation Common Stock (CHRN) 10K Form and Latest SEC Filings 2026 - MarketBeat
ChronoScale Corporation Common Stock (CHRN) Insider Trading Activity 2026 - MarketBeat
ChronoScale Corporation Common Stock (CHRN) Stock Price, News & Analysis - MarketBeat
CHRN PE Ratio & Valuation, Is CHRN Overvalued - Intellectia AI
Ekso Bionics Holdings, Inc. Common Stock (CHRN) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Ekso Bionics Holdings Inc (EKSO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ekso Bionics Holdings Inc 주식 (EKSO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wong Jerome | Chief Financial Officer |
Mar 16 '26 |
Buy |
11.85 |
1,308 |
15,500 |
4,184 |
| ASHER DANIEL | 10% Owner |
Feb 19 '26 |
Buy |
12.30 |
15,540 |
191,162 |
270,432 |
| ASHER DANIEL | 10% Owner |
Feb 19 '26 |
Buy |
9.60 |
1,200 |
11,520 |
259,992 |
| ASHER DANIEL | 10% Owner |
Feb 12 '26 |
Buy |
9.57 |
39,032 |
373,656 |
231,600 |
| ASHER DANIEL | 10% Owner |
Feb 13 '26 |
Buy |
9.04 |
27,192 |
245,687 |
258,792 |
| ASHER DANIEL | 10% Owner |
Feb 11 '26 |
Buy |
9.69 |
20,611 |
199,770 |
192,568 |
| ASHER DANIEL | 10% Owner |
Feb 10 '26 |
Buy |
9.92 |
10,200 |
101,225 |
171,957 |
| ASHER DANIEL | 10% Owner |
Feb 09 '26 |
Buy |
9.96 |
4,800 |
47,820 |
161,757 |
| ASHER DANIEL | 10% Owner |
Feb 06 '26 |
Buy |
9.86 |
194 |
1,912 |
156,957 |
| Jones Jason C | Chief Operating Officer |
Jan 06 '26 |
Sale |
9.25 |
1,320 |
12,210 |
25,621 |
3.37%
0.73%
자본화:
|
볼륨(24시간):